212 related articles for article (PubMed ID: 19289781)
1. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
2. Subacute cutaneous lupus erythematosus induced by capecitabine.
Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
[No Abstract] [Full Text] [Related]
3. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
[No Abstract] [Full Text] [Related]
4. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Ko JH; Hsieh CI; Chou CY; Wang KH
J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
[No Abstract] [Full Text] [Related]
6. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
7. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
8. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
9. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.
Merlin F; Prochilo T; Kildani B; Lombardi C; Pasolini G; Bonetti F; Beretta GD
Int J Colorectal Dis; 2008 Jul; 23(7):715-6. PubMed ID: 18330579
[No Abstract] [Full Text] [Related]
10. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
11. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
[No Abstract] [Full Text] [Related]
12. [The prevention of diarrhea while under capecitabine therapy].
Grouls V
Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
[No Abstract] [Full Text] [Related]
13. [Capecitabine-induced hyperpigmentation].
Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
[TBL] [Abstract][Full Text] [Related]
14. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
15. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
16. Nursing considerations for capecitabine-based combination therapy.
Becze E
ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
[No Abstract] [Full Text] [Related]
17. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
Aksoy S; Karaca B; Dinçer M; Yalçin S
Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
[No Abstract] [Full Text] [Related]
18. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
González-Haba E
Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
[No Abstract] [Full Text] [Related]
19. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
20. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
